echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: The prognostic relationship of neurofilament, CHIT1, YKL-40 and MCP-1 in patients with amyotrophic lateral sclerosis

    JNNP: The prognostic relationship of neurofilament, CHIT1, YKL-40 and MCP-1 in patients with amyotrophic lateral sclerosis

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the progressive loss of motor neurons in the brain, brainstem, and spinal cord
    .


    This can lead to progressive muscle weakness and weight loss


    Cerebrospinal fluid (CSF) and neurofilaments (Nfs) in the blood have been shown to reflect the degree of motor neuron degeneration and predict the survival rate of patients with ALS (pALS)


    Three neuroinflammation markers with good performance at the diagnostic and prognostic level of ALS were selected: chitotriosidase (CHIT1), chitinase 3-like protein 1 (YKL-40) and monocyte chemotactic protein (MCP) -1)


    This article was published in " Journal of Neurology, Neurosurgery & Psychiatry " ( Journal of Neurology, Neurosurgery & Psychiatry ) This article was published in " Journal of Neurology, Neurosurgery & Psychiatry " ( Journal of Neurology, Neurosurgery & Psychiatry ) This article was published in theJournal of Neurology, Neurosurgery & Psychiatry(Journal of Neurology, Neurosurgery & Psychiatry)

    PALS patients were recruited in two centers
    .


    Including sporadic ALS (sALS), ALS caused by repeated amplification of C9orf72 (C9-ALS) and asymp-C9


    Similar results were also found when pNfH was combined with YKL-40 (Supplementary Figure 1 online)


    The combination of NfL and YKL-40 levels predicts the survival rate of patients with amyotrophic lateral sclerosis
    to further explore the relationship between these biomarkers in predicting survival, and incorporate these biomarkers into a model that contains eight established models Prognostic factors (medullary and non-bulbar onset, age of onset, presence of clear ALS, delay in diagnosis, forced vital capacity, progression rate, frontotemporal dementia (FTD) and the presence of repeat expansion of C9orf72
    .


    When included in this model, The increased level is independently related to the shorter survival rate of each biomarker



    In short, although CHIT1 levels have a better correlation with Nfs, YKL-40 has the most significant added value to Nfs to predict the survival of pALS


    MasroriP ,De SchaepdryverM ,FloeterMK MasroriPMasrori De SchaepdryverMDe Schaepdryver FloeterMKFloeter, et alJournal of Neurology, Neurosurgery & PsychiatryPublished Online First:15 December 2021.
     Published Online First: doi:10.
    1136/jnnp-2021- 327877doi:leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.